{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:23:08Z","timestamp":1790871788199,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,5,12]],"date-time":"2009-05-12T00:00:00Z","timestamp":1242086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1245\/s10434-009-0507-4","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T15:28:25Z","timestamp":1242055705000},"page":"2331-2338","source":"Crossref","is-referenced-by-count":16,"title":["Coordinate Loss of Fragile Gene Expression in Pancreatobiliary Cancers: Correlations Among Markers and Clinical Features"],"prefix":"10.1245","volume":"16","author":[{"given":"Mark","family":"Bloomston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Kneile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dillhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Muscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Christopher","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Melvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Pichiorri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy L.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"507_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43\u201366.","journal-title":"CA Cancer J Clin"},{"key":"507_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2005.06.048","volume":"232","author":"D Iliopoulos","year":"2006","unstructured":"Iliopoulos D, Guler G, Han SY, Druck T, Ottey M, McCorkell KA, et al. Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett. 2006;232:27\u201336.","journal-title":"Cancer Lett"},{"key":"507_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00595-005-3094-4","volume":"36","author":"T Kuroki","year":"2006","unstructured":"Kuroki T, Tajima Y, Furui J, Kanematsu T. Common fragile genes and digestive tract cancers. Surg Today. 2006;36:1\u20135.","journal-title":"Surg Today"},{"key":"507_CR4","first-page":"4347","volume":"56","author":"R Shridhar","year":"1996","unstructured":"Shridhar R, Shridhar V, Wang X, Paradee W, Dugan M, Sarkar F, et al. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res. 1996;56:4347\u201350.","journal-title":"Cancer Res"},{"key":"507_CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<239::AID-GCC3>3.0.CO;2-X","volume":"27","author":"W Hilgers","year":"2000","unstructured":"Hilgers W, Koerkamp BG, Geradts J, Tang DJ, Yeo CJ, Hruban RH, et al. Genomic FHIT analysis in RER\u00a0+\u00a0and RER- adenocarcinomas of the pancreas. Genes Chromosomes Cancer. 2000;27:239\u201343.","journal-title":"Genes Chromosomes Cancer"},{"key":"507_CR6","first-page":"1308","volume":"59","author":"C Sorio","year":"1999","unstructured":"Sorio C, Baron A, Orlandini S, Zamboni G, Pederzoli P, Huebner K, et al. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. Cancer Res. 1999;59:1308\u201314.","journal-title":"Cancer Res"},{"key":"507_CR7","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-03-0096","volume":"10","author":"T Kuroki","year":"2004","unstructured":"Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan RI, Alder H, et al. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res. 2004;10:2459\u201365.","journal-title":"Clin Cancer Res"},{"key":"507_CR8","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1349-7006.2008.00841.x","volume":"99","author":"S Nakayama","year":"2008","unstructured":"Nakayama S, Semba S, Maeda N, Aqeilan RI, Huebner K, Yokozaki H. Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells. Cancer Sci. 2008;99:1370\u20136.","journal-title":"Cancer Sci"},{"key":"507_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-4598-2-7","volume":"2","author":"PS Moore","year":"2003","unstructured":"Moore PS, Beghelli S, Zamboni G, Scarpa A. Genetic abnormalities in pancreatic cancer. Mol Cancer. 2003;2:7.","journal-title":"Mol Cancer"},{"key":"507_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","volume":"3","author":"A Maitra","year":"2008","unstructured":"Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol. 2008;3:157\u201388.","journal-title":"Annu Rev Pathol"},{"key":"507_CR11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.20137","volume":"100","author":"G Guler","year":"2004","unstructured":"Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, et al. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer. 2004;100:1605\u201314.","journal-title":"Cancer"},{"key":"507_CR12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1440-1827.2005.01855.x","volume":"55","author":"G Guler","year":"2005","unstructured":"Guler G, Uner A, Guler N, Han SY, Iliopoulos D, McCue P, et al. Concordant loss of fragile gene expression early in breast cancer development. Pathol Int. 2005;55:471\u20138.","journal-title":"Pathol Int"},{"key":"507_CR13","doi-asserted-by":"crossref","first-page":"13736","DOI":"10.1074\/jbc.M709062200","volume":"283","author":"F Trapasso","year":"2008","unstructured":"Trapasso F, Pichiorri F, Gaspari M, Palumbo T, Ageilan RI, Gaudio E, et al. Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem. 2008;283:13736\u201344.","journal-title":"J Biol Chem"},{"key":"507_CR14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm1001-1111","volume":"7","author":"PM Hwang","year":"2001","unstructured":"Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med. 2001;7:1111\u20137.","journal-title":"Nat Med"},{"key":"507_CR15","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1038\/sj.onc.1205862","volume":"21","author":"G Liu","year":"2002","unstructured":"Liu G, Chen X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene. 2002;21:7195\u2013204.","journal-title":"Oncogene"},{"key":"507_CR16","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","volume":"297","author":"M Bloomston","year":"2007","unstructured":"Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901\u20138.","journal-title":"JAMA"},{"key":"507_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000093497","volume":"23","author":"M Bloomston","year":"2006","unstructured":"Bloomston M, Bhardwaj A, Ellison EC, Frankel WL. Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique. Dig Surg. 2006;23:74\u20139.","journal-title":"Dig Surg"},{"key":"507_CR18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1245\/s10434-006-9128-3","volume":"14","author":"M Bloomston","year":"2007","unstructured":"Bloomston M, Ellison EC, Muscarella P, Al-Saif O, Martin EW, Melvin WS, et al. Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer. Ann Surg Oncol. 2007;14:211\u20137.","journal-title":"Ann Surg Oncol"},{"key":"507_CR19","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1158\/1078-0432.CCR-03-0594","volume":"10","author":"RI Aqeilan","year":"2004","unstructured":"Aqeilan RI, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baffa R, et al. Loss of WWOX expression in gastric carcinoma. Clin Cancer Res. 2004;10:3053\u20138.","journal-title":"Clin Cancer Res"},{"key":"507_CR20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3748\/wjg.v13.i7.1018","volume":"13","author":"J Cao","year":"2007","unstructured":"Cao J, Chen XP, Li WL, Xia J, Du H, Tang WB, et al. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition. World J Gastroenterol. 2007;13:1018\u201326.","journal-title":"World J Gastroenterol"},{"key":"507_CR21","first-page":"E8","volume":"94","author":"X Feng","year":"2007","unstructured":"Feng X, Li L, Gao Y, Zhang J, Ying J, Xiao T, et al. Fhit protein expression in lung cancer studied by high-throughput tissue microarray. Bull Cancer. 2007;94:E8\u201311.","journal-title":"Bull Cancer"},{"key":"507_CR22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.bjc.6603512","volume":"96","author":"G Terry","year":"2007","unstructured":"Terry G, Ho L, Londesborough P, Duggan C, Hanby A, Cuzick J. The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. Br J Cancer. 2007;96:110\u20137.","journal-title":"Br J Cancer"},{"key":"507_CR23","first-page":"5032","volume":"58","author":"G Sozzi","year":"1998","unstructured":"Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res. 1998;58:5032\u20137.","journal-title":"Cancer Res"},{"key":"507_CR24","first-page":"1583","volume":"58","author":"B Simon","year":"1998","unstructured":"Simon B, Bartsch D, Barth P, Prasnikar N, M\u00fcnch K, Blum A, et al. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. Cancer Res. 1998;58:1583\u20137.","journal-title":"Cancer Res"},{"key":"507_CR25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mc.10099","volume":"36","author":"T Tsujiuchi","year":"2003","unstructured":"Tsujiuchi T, Sasaki Y, Kubozoe T, Konishi Y, Tsutsumi M. Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters. Mol Carcinog. 2003;36:60\u20136.","journal-title":"Mol Carcinog"},{"key":"507_CR26","first-page":"4827","volume":"61","author":"KR Dumon","year":"2001","unstructured":"Dumon KR, Ishii H, Vecchione A, Trapasso F, Baldassarre G, Chakrani F, et al. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. Cancer Res. 2001;61:4827\u201336.","journal-title":"Cancer Res"},{"key":"507_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3835(03)00385-9","volume":"199","author":"M Koda","year":"2003","unstructured":"Koda M, Yashima K, Kawaguchi K, Andachi H, Hosoda A, Shiota G, et al. Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma. Cancer Lett. 2003;199:131\u20138.","journal-title":"Cancer Lett"},{"key":"507_CR28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2006.09.019","volume":"250","author":"E Riquelme","year":"2007","unstructured":"Riquelme E, Tang M, Baez S, Diaz A, Pruyas M, Wistuba, II, et al. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma. Cancer Lett. 2007;250:100\u20136.","journal-title":"Cancer Lett"},{"key":"507_CR29","first-page":"45","volume":"53","author":"L Chen","year":"2006","unstructured":"Chen L, Tao SF, Zheng YX. Prognostic significance of vascular endothelial growth factor expression and microvessel density in carcinoma of ampulla of Vater. Hepatogastroenterology. 2006;53:45\u201350.","journal-title":"Hepatogastroenterology"},{"key":"507_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jcp.2006.037333","volume":"61","author":"D Fong","year":"2006","unstructured":"Fong D, Steurer M, Obrist P, et al. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. J Clin Pathol. 2006;61:31\u20135.","journal-title":"J Clin Pathol"},{"key":"507_CR31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11605-007-0136-9","volume":"11","author":"C Iacono","year":"2007","unstructured":"Iacono C, Verlato G, Zamboni G, Scarpa A, Montresor E, Capelli P, et al. Adenocarcinoma of the ampulla of Vater: T-Stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors. J Gastrointest Surg. 2007;11:578\u201388.","journal-title":"J Gastrointest Surg"},{"key":"507_CR32","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4161\/cbt.6.10.4725","volume":"6","author":"R Lucito","year":"2007","unstructured":"Lucito R, Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, et al. Copy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biol Ther. 2007;6:1592\u20139.","journal-title":"Cancer Biol Ther"},{"key":"507_CR33","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1158\/1078-0432.CCR-07-1282","volume":"13","author":"G Guler","year":"2007","unstructured":"Guler G, Iliopoulos D, Guler N, Himmetoglu C, Hayran M, Huebner K. Wwox and Ap2gamma expression levels predict tamoxifen response. Clin Cancer Res. 2007;13:6115\u201321.","journal-title":"Clin Cancer Res"},{"key":"507_CR34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcp.21099","volume":"212","author":"RI Aqeilan","year":"2007","unstructured":"Aqeilan RI, Croce CM. WWOX in biological control and tumorigenesis. J Cell Physiol. 2007;212:307\u201310.","journal-title":"J Cell Physiol"},{"key":"507_CR35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molmed.2006.11.006","volume":"13","author":"NS Chang","year":"2007","unstructured":"Chang NS, Hsu LJ, Lin YS, Lai FJ, Sheu HM. WW domain-containing oxidoreductase: a candidate tumor suppressor. Trends Mol Med. 2007;13:12\u201322.","journal-title":"Trends Mol Med"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0507-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-009-0507-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0507-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:33:33Z","timestamp":1572971613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-009-0507-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0507-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]}}}